Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05OTL
|
||||
| Former ID |
DIB008783
|
||||
| Drug Name |
NW-3509
|
||||
| Synonyms |
NW-3381; Sodium channel blockers (epilepsy/pain/mania), Newron
|
||||
| Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Phase 1 | [548597] | ||
| Company |
Newron pharmaceuticals
|
||||
| Canonical SMILES |
c1(cccc(c1)CCNCC(=O)N(C)C)OCCCC.Cl
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Blocker | [551426] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.